USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: NANOSCALE MATERIALS, INC.
Address: 1310 RESEARCH PARK DR
MANHATTAN, KS 66502-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $200,000.00 1
SBIR Phase II $1,000,000.00 1
STTR Phase I $100,000.00 1

Award List:

FUNCTIONALIZED BIMAGNETIC CORE/SHELL FE/FE3O4 STEALTH NANOPART

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Franklin Kroh
Award Amount: $1,000,000.00
Abstract:
Early diagnosis and treatment of cancer greatly improve the likelihood of long-term survival and health. In Phase I, NanoScale Corporation and its partners at Kansas State University developed functionalized cancer-seeking "stealth" Fe/Fe3O4 core/shell nanoparticles, and demonstrated their… More

Protective Apparel Fabrics (PAF) with Distinctly Area-Specific Waterproof and Breathable Properties

Award Year / Program / Phase: 2010 / STTR / Phase I
Agency: DOE
Research Institution: Clemson University
Principal Investigator: Shyamala Rajagopalan, Dr.
Award Amount: $100,000.00
RI Contact: Christine Cole
Abstract:
The end of the Cold War left the DOE with a surplus of nuclear facilities, which must now be deactivated and decommissioned (D&D). Appropriate protective apparel capable of shielding workers against a variety of hazardous materials such as airborne plutonium, mercury, organic solvents, asbestos, and… More

DEVELOPMENT OF A RAPID IN VITRO SCREENING ASSAY FOR DETECTION OF CANCER BIOMARKERS IN URINE AND BLOOD.

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Frank Kroh – 785-537-0179
Award Amount: $200,000.00
Abstract:
The goal of the project is to develop a rapid in vitro screening assay for detection of cancer biomarkers in urine and blood. The aim is testing and optimization of nanoparticle sensors, based on cyanine dyes that are chemically linked to Fe/Fe3O4 nanoparticles via protease-selective consensus… More